Role of contrast-enhanced ultrasound (CEUS) in evaluation of thermal ablation zone

Jemal A, Bray F, Center MM, et al. (2011) Global cancer statistics. CA 61(2):69–90

ElSerag HB, Kanwal F (2014) Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go? Hepatology 60(5):1767–1775

Namasivayam S, Martin DR, Saini S (2007) Imaging of liver metastases: MRI. Cancer Imaging 7:2–9

Bruix J, Gores GJ, Mazzaferro V (2014) Hepatocellular carcinoma: clinical frontiers and perspectives. Gut 63(5):844–855

Waki K, Aikata H, Katamura Y, et al. (2010) Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up. J Gastroenterol Hepatol 25(3):597–604

Hwang J, Kim SH, Kim YS, et al. (2010) Gadoxetic acid-enhanced MRI versus multiphase multidetector row computed tomography for evaluating the viable tumor of hepatocellular carcinomas treated with image-guided tumor therapy. J Magn Reson Imaging 32(3):629–638

Yoon JH, Lee EJ, Cha SS, et al. (2010) Comparison of gadoxetic acid-enhanced MR imaging versus four-phase multi-detector row computed tomography in assessing tumor regression after radiofrequency ablation in subjects with hepatocellular carcinomas. J Vasc Interv Radiol 21(3):348–356

Claudon M, Dietrich CF, Choi BI, et al. (2013) Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver: update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol 39(2):187–210

Albrecht T, Blomley M, Bolondi L, et al. (2004) Guidelines for the use of contrast agents in ultrasound January 2004. Ultraschall Med 25(4):249–256

Wilson SR, Greenbaum LD, Goldberg BB (2009) Contrast-enhanced ultrasound: what is the evidence and what are the obstacles? AJR Am J Roentgenol 193(1):55–60

Wilson SR, Jang HJ, Kim TK, Burns PN (2007) Diagnosis of focal liver masses on ultrasonography: comparison of unenhanced and contrast-enhanced scans. J Ultrasound Med 26(6):775–787 (quiz 88–90)

Quaia E, D’Onofrio M, Palumbo A, et al. (2006) Comparison of contrast-enhanced ultrasonography versus baseline ultrasound and contrast-enhanced computed tomography in metastatic disease of the liver: diagnostic performance and confidence. Eur Radiol 16(7):1599–1609

Meloni MF, Andreano A, Zimbaro F, et al. (2012) Contrast enhanced ultrasound: Roles in immediate post-procedural and 24-h evaluation of the effectiveness of thermal ablation of liver tumors. J Ultrasound 15(4):207

Choi D, Lim HK, Lee WJ, et al. (2003) Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent. J Ultrasound Med 22(11):1163–1172

Morimoto M, Nozawa A, Numata K, et al. (2005) Evaluation using contrast-enhanced harmonic gray scale sonography after radio frequency ablation of small hepatocellular carcinoma: sonographic-histopathologic correlation. J Ultrasound Med 24(3):273–283

Kim CK, Choi D, Lim HK, et al. (2005) Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging. Eur J Radiol 56(1):66–73

Ding H, Kudo M, Onda H, et al. (2001) Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 221(3):721–730

Kim TK, Khalili K (2015) Local ablation therapy with contrast-enhanced ultrasonography for hepatocellular carcinoma: a practical review. 34(4):235–245

Zheng SG, Xu HX, Liu LN (2014) Management of hepatocellular carcinoma: the role of contrast-enhanced ultrasound. World J Radiol 6(1):7–14

Dohmen T, Kataoka E, Yamada I, et al. (2012) Efficacy of contrast-enhanced ultrasonography in radiofrequency ablation for hepatocellular carcinoma. Intern Med 51:1–7

Guibal A, Bertin C, Egels S, et al. (2013) Contrast-enhanced ultrasound (CEUS) follow-up after radiofrequency ablation or cryoablation of focal liver lesions: treated-area patterns and their changes over time. Eur Radiol 23(5):1392–1400

Wilson SR, Burns PN, Wilkinson LM, Simpson DH, Muradali D (1999) Gas at abdominal US: appearance, relevance, and analysis of artifacts. Radiology 210(1):113–123

Yu H, Jang HJ, Kim TK, et al. (2010) Pseudoenhancement within the local ablation zone of hepatic tumors due to a nonlinear artifact on contrast-enhanced ultrasound. AJR Am J Roentgenol 194(3):653–659